Ftse Mib
36.203,08
-0,74%
DAX
21.428,24
-1,30%
S&P 500
5.994,57
-0,76%
NASDAQ
19.391,96
-1,20%
Bitcoin
101.630,01
4,02%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Acrivon Therapeutics Inc (ACRV) Acrivon Therapeutics Inc (ACRV) Notizie

Acrivon Therapeutics Inc

ACRV
5,57
-0,50 (-8,24%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:43:51
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/1/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202413:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202413:00EDGAR2Form 8-K - Current report
13/11/202413:00GLOBEAcrivon Therapeutics Reports Third Quarter 2024 Financial..
21/10/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202414:00GLOBEAcrivon Therapeutics to Present Data Demonstrating..
16/10/202422:00GLOBEAcrivon Therapeutics Announces Inducement Grant Under Nasdaq..
11/10/202414:00EDGAR2Form 8-K - Current report
11/10/202414:00GLOBEAcrivon Therapeutics Announces Initial Patient Dosing in..
04/10/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202412:43EDGAR2Form 8-K - Current report
14/9/202409:10GLOBEAcrivon Therapeutics Reports Positive Endometrial Cancer..
10/9/202414:00GLOBEAcrivon Therapeutics to Present at the Cantor Global..
09/9/202413:00GLOBEAcrivon Therapeutics to Host Virtual Investor Event to..
23/8/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202414:00EDGAR2Form 8-K - Current report
13/8/202414:00GLOBEAcrivon Therapeutics Reports Second Quarter 2024 Financial..
13/8/202413:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/7/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202414:00GLOBEAcrivon Therapeutics to Present at the Jefferies Global..
21/5/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202414:00EDGAR2Form 8-K - Current report
14/5/202414:00GLOBEAcrivon Therapeutics Reports First Quarter 2024 Financial..
Apertura: 6,07 Min: 5,46 Max: 6,07
Chiusura: 6,07

La tua Cronologia

NASDAQ
ACRV
Acrivon Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci